后颅窝动静脉畸形中存在直接椎基底动脉穿支供血与血管内治疗后不良结局相关
该研究回顾性分析1995至2018年一家医院连续收治的114例后颅窝动静脉畸形(PFAVM)患者,其中101例接受治疗,随访平均47.6个月。末次随访时78.2%获良好神经功能结局,治疗后造影闭塞率68.3%。存在直接椎基底动脉穿支供血与神经功能恶化和较低闭塞率相关。
要点
- 114例PFAVM中88例(77.2%)有出血史,101例(88.6%)接受治疗。
- 直接椎基底动脉穿支供血与神经功能恶化(OR 5.63)及较低闭塞率(OR 15.69)相关。
- 血管内治疗并发症率仍高,需仔细筛选可能获益的患者亚组。
核心结论
- 血管内技术进步使PFAVM闭塞率提高,但并发症率仍高,直接椎基底动脉穿支供血的存在应质疑血管内治疗指征。
研究设计与样本
- 回顾性分析1995年至2018年Fondation Rothschild医院连续收治的PFAVM病例,临床、影像和治疗数据前瞻性收集,分析长期结局。
主要发现
- 1311例脑动静脉畸形中114例(8.7%)为PFAVM,88例(77.2%)有出血史。
- 114例PFAVM中101例(88.6%)接受治疗(83例破裂,18例未破裂),平均随访47.6个月(范围0-240个月)。
- 末次随访良好神经功能结局79例(78.2%),随访造影显示治疗病例闭塞率68.3%。
- 直接椎基底动脉穿支供血与神经功能恶化相关(OR 5.63,95%CI 11.15-30.76),与较低闭塞率相关(OR 15.69,95%CI 2.52-304.03)。
- 神经功能恶化和闭塞率的其他预测因素与Spetzler-Martin分级系统一致。
临床怎么用
- 作者认为,必须仔细筛选可能从治疗中获益的患者亚组,直接椎基底动脉穿支供血的存在应质疑血管内治疗指征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Treatment of posterior fossa arteriovenous malformations (PFAVMs) remains controversial as it is always challenging and may lead to major complications. Nonetheless, these lesions are more likely to bleed and generate poorer outcomes than other brain AVMs. The aim of this study was to evaluate the effect of endovascular treatment on long-term outcomes and identify the patient subgroups that might benefit from endovascular treatment. METHODS: The authors performed a retrospective analysis of all consecutive cases of PFAVM managed at the Fondation Rothschild Hospital between 1995 and 2018. Clinical, imaging, and treatment data were prospectively gathered; these data were analyzed with respect to long-term outcomes. RESULTS: Among the 1311 patients with brain AVMs, 114 (8.7%) had a PFAVM, and 88 (77.2%) of these patients had a history of bleeding. Of the 114 PFAVMs, 101 (88.6%) were treated (83 ruptured and 18 unruptured). The mean duration of follow-up was 47.6 months (range 0-240 months). Good neurological outcome at last follow-up was achieved in 79 cases (78.2%). Follow-up angiography showed obliteration of the PFAVM in 68.3% of treated cases. The presence of direct vertebrobasilar perforator feeders was associated with neurological deterioration (OR 5.63, 95% CI 11.15-30.76) and a lower obliteration rate (OR 15.69, 95% CI 2.52-304.03) after endovascular treatment. Other predictors of neurological deterioration and obliteration rate were consistent with the Spetzler-Martin grading system. CONCLUSIONS: Advances in endovascular techniques have enabled higher obliteration rates in the treatment of PFAVMs, but complication rates are still high. Subgroups of patients who might benefit from treatment must be carefully selected and the presence of direct vertebrobasilar perforator feeders must call into question the indication for endovascular treatment.
引用
- Lefevre E, Robert T, Escalard S, et al. Presence of direct vertebrobasilar perforator feeders in posterior fossa arteriovenous malformations and association with poor outcomes after endovascular treatment. J Neurosurg. 2019. PMID: 31703199. doi:10.3171/2019.8.JNS191971
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。